CDH23 and cancer: Although our method excels in both overall pathogenicity prediction for membrane proteins and multi-label disease classification, there is still room for improvement in terms of prediction accuracy for some specific diseases (e.g., cancer) as well as for some specific proteins (e.g., Cadherin-23).